Patients with so-called high-grade prostate cancer often struggle with severe side effects after a standard treatment. Our data shows that IRE as a treatment method…Read More
Radioligand therapy (RLT) using Lu-177 labelled PSMA is a novel and promising therapeutic approach to treat metastatic prostate cancer. We explain how the therapy works. Lu-177…Read More
Prof. Dr. Michael Stehling talks about the rationale and the advantages of using NanoKnife (IRE) for the treatment of prostate cancer.
NanoKnife (IRE) is the latest technology to treat prostate cancer. This short video demonstrates the out patient treatment of prostate cancer with NanoKnife (IRE).
Dr. Israel Barken independently reviewed our data and comments on the treatment of prostate cancer with NanoKnife (IRE).